April 06, 2022
Nordic Nanovector ASA Announces Proposed Board Changes – Former Algeta CEO Thomas Ramdahl nominated to Join Board of Directors
Media
March 30, 2022
Aro Biotherapeutics to Highlight Therapeutic Potential of Centyrin Oligonucleotide Conjugates at Upcoming Industry Conferences
March 23, 2022
Michael Wolff Jensen resigns from the Vicore board of directors and is replaced by Jacob Gunterberg as chairman of the board up until the annual general meeting in May 2022
March 18, 2022
Vicore initiates human forearm blood flow study with C21
March 17, 2022
Fusion Pharmaceuticals Announces Fourth Quarter 2021 Financial Results And Clinical Program Updates
March 16, 2022
Xeris Biopharma Announces Gvoke® Kit Is Now Available for the Treatment of Severe Hypoglycemia in Adults and Children With Diabetes Ages 2 And Above
March 16, 2022
Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals
March 15, 2022
Aprea Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Update on Business Operations
March 14, 2022
Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates
March 14, 2022
Spruce Biosciences Appoints Will Charlton, M.D., M.A.S., as Chief Medical Officer